Add-On Lamotrigine Treatment in Children and Young Adults With Severe Partial Epilepsy: An Open, Prospective, Long-Term Study

2000 ◽  
Vol 15 (10) ◽  
pp. 671-674 ◽  
Author(s):  
Lucio Parmeggiani ◽  
Anna Belmonte ◽  
Anna Rita Ferrari ◽  
Emilio Perucca ◽  
Renzo Guerrini
Keyword(s):  
Young Adults ◽  
Partial Epilepsy ◽  
Term Study ◽  
Long Term Study ◽  
Children And Young Adults

A Month-by-Month Long-Term Study on Carbamazepine: Clinical, EEG and Pharmacological Evaluation

1979 ◽  
Vol 7 (2) ◽  
pp. 152-157 ◽  
Author(s):  
F Monaco ◽  
A Riccio ◽  
M Fantini ◽  
A Baruzzi ◽  
P L Morselli
Keyword(s):  
Side Effects ◽  
Plasma Levels ◽  
Partial Epilepsy ◽  
Term Study ◽  
Breakdown Rate ◽  
Long Term Study ◽  
First Choice ◽  
Epileptic Patients ◽  
Clinical Eeg

Carbamazepine plasma levels were monitored for a twelve-month period in twenty epileptic patients. Seizure frequency decreased remarkably on inclusion of the drug in the therapy and attainment of plasma levels of 7–9 μg/ml. A faster breakdown rate in children was confirmed, while carbamazepine-10, 11-epoxide was present for carbamazepine levels above 4–5 μg/ml. EEG tracings did not show substantial modifications; this variable was thus considered to be of little value in assessing the clinical picture. Side-effects were minimal. Carbamazepine is increasingly becoming the drug of first choice in the management of both generalized and partial epilepsy, while better and more rapid results are obtained in monotherapy.

Quinapril for Sclerosis Failed in Long-Term Study

2007 ◽  
Vol 38 (6) ◽  
pp. 14
Author(s):  
DAMIAN MCNAMARA
Keyword(s):  
Term Study ◽  
Long Term Study
Sign in / Sign up

Export Citation Format

Share Document